Clinical Trials
3 trialsNCT03836300 2025-07-31
Parent and Infant Inter(X)Action Intervention (PIXI)
RTI International
Phase NA Enrolling by invitation
NCT01906866 2024-04-23
Efficacy and Safety of CircadinĀ® in the Treatment of Sleep Disturbances in Children With Neurodevelopment Disabilities
Neurim Pharmaceuticals Ltd.
Phase 3 Completed
NCT01903681 2014-04-04
Assessment of the Pharmacokinetics of CircadinĀ® in Children With Neurodevelopmental Disorders and Sleep Disturbances
Neurim Pharmaceuticals Ltd.
Phase 1 Completed